Summary
Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.
- The Russian pharmaceuticals market recorded revenues of $13.9 billion in 2024, representing a compound annual growth rate (CAGR) of 3.4% between 2019 and 2024.
- The anti-infective drugs segment accounted for the market's largest proportion in 2024, with total revenues of $2.0 billion, equivalent to 14.1% of the market's overall value.
- The Russian pharmaceuticals market witnessed healthy growth in 2024, registering an annual growth of 6.7%.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Russia
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Russia
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Russia pharmaceuticals market with five year forecasts
Reasons to Buy
- What was the size of the Russia pharmaceuticals market by value in 2024?
- What will be the size of the Russia pharmaceuticals market in 2029?
- What factors are affecting the strength of competition in the Russia pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Russia's pharmaceuticals market?
'
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the recent developments in the market?
8 Company Profiles
8.1. Bayer AG
8.2. Pharmstandard
8.3. Binnopharm Group
8.4. OTC Pharma International BV
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Russia pharmaceuticals market value: $ million, 2019-24
Table 2: Russia pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 3: Russia pharmaceuticals market category segmentation: $ million, 2019-24
Table 4: Russia pharmaceuticals market geography segmentation: $ million, 2024
Table 5: Russia pharmaceuticals market value forecast: $ million, 2024-29
Table 6: Bayer AG: Key Facts
Table 7: Bayer AG: Annual Financial Ratios
Table 8: Bayer AG: Key Employees
Table 9: Bayer AG: Key Employees Continued
Table 10: Bayer AG: Key Employees Continued
Table 11: Pharmstandard: Key Facts
Table 12: Pharmstandard: Key Employees
Table 13: Binnopharm Group: Key Facts
Table 14: Binnopharm Group: Key Employees
Table 15: OTC Pharma International BV: Key Facts
Table 16: OTC Pharma International BV: Key Employees
Table 17: Russia Size of Population (Million), 2020-24
Table 18: Russia Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 19: Russia GDP (Current Prices, $ Billion), 2020-24
Table 20: Russia Inflation, 2020-24
Table 21: Russia Consumer Price Index (Absolute), 2020-24
Table 22: Russia Exchange Rate, 2019-24
List of Figures
Figure 1: Russia pharmaceuticals market value: $ million, 2019-24
Figure 2: Russia pharmaceuticals market category segmentation: $ million, 2019-24
Figure 3: Russia pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 4: Russia pharmaceuticals market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the pharmaceuticals market in Russia, 2024
Figure 6: Drivers of buyer power in the pharmaceuticals market in Russia, 2024
Figure 7: Drivers of supplier power in the pharmaceuticals market in Russia, 2024
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2024
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2024
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2024
